Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
Status:
Completed
Trial end date:
2001-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine whether physiologic testosterone replacement can increase fat-free
mass, therefore contributing to weight maintenance, improved muscle function, and quality of
life in HIV-infected women.
II. Examine the mechanism of testosterone-induced increase in fat-free mass.